How much does Rhapsido (Remibrutinib Tablets) Cost& price without insurance in China?
Rhapsido® is the commercial brand name of Remibrutinib Tablets, an orally selective BTK inhibitor developed by BeiGene. It inhibits Bruton’s tyrosine kinase to block abnormal B-cell activation and reduce inflammatory response.
Main Indications
Treatment of adult patients with chronic spontaneous urticaria inadequately controlled by second-generation antihistamines.
Common Side Effects
Common mild adverse reactions: Headache, upper respiratory tract infection, fatigue and nausea.
Laboratory abnormalities: Transient liver enzyme elevation.
Severe but uncommon risks: Severe infection, severe bleeding events and hypersensitivity reactions.
Approval Status in China
Rhapsido® (Remibrutinib Tablets, 25mg) was officially approved for marketing in China in 2024. It is currently a prescription drug included in China’s Category B medical insurance.
Buy Rhapsido (Remibrutinib Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
